The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: boohoo Latest To Snap Up Arcadia Brands

Mon, 08th Feb 2021 07:49

(Alliance News) - Stock prices in London were seen opening higher on Monday, with optimism over a US stimulus package offsetting concerns about the AstraZeneca and Oxford University Covid-19 vaccine.

IG futures indicate the FTSE 100 index is to open 30.2 points higher at 6,519.53. The blue-chip index closed down 0.2%, or 14.39 points at 6,489.33 on Friday.

In early corporate news on Monday, Experian said it is continuing a "detailed forensic investigation" following a Brazilian data leak, but noted that evidence suggests its technology systems have not been compromised.

Among mid-caps, Electrocomponents posted improved revenue for the four-months to January 31 and Drax unveiled a sizeable Canadian acquisition.

AIM-listed online retailer boohoo Group has forked out just over GBP25 million for the e-commerce and digital assets of Burton, Dorothy Perkins and Wallis, three Arcadia Group brands.

Equity markets rallied early on Monday with Asian stocks soaring and London futures in positive territory, despite "significant bad vaccine news over the weekend", analysts at Danske Bank noted.

"A new study suggests that AstraZeneca has only limited efficacy versus the South African variant, at least for mild diseases," Danske Bank analysts said.

South Africa has temporarily suspended the AstraZeneca and Oxford University jab against a new variant found in the country, according to the health department and top local scientists.

The AstraZeneca-Oxford vaccine protects against the original Covid-19 strain, but its efficacy drops off substantially when it comes to the new variant called B.1.351 or 501.V2, raising serious concerns, said Shabir Madhi, the professor of vaccinology at the University of the Witwatersrand, citing a new local study involving 2,000 participants.

Danske Bank analysts also noted the "expectations for a significant fiscal stimulus package from US".

US President Joe Biden seized on feeble US employment data, published on Friday, to argue the world's largest economy needs his USD1.9 trillion pandemic relief package, which cleared a key Senate hurdle without support from the Republican opposition.

"I believe the American people are looking right now to their government for help," Biden said after a meeting with top Democratic lawmakers. "So I'm going to act. I'm going to act fast."

Back in the UK, Rolls-Royce is planning to shut down its jet engine factories this summer due to insufficient work, the Telegraph reported on Saturday.

According to the newspaper, this is a first time Roll-Royce has done this and results from what Rolls-Royce described as a "significantly reduced" workload resulting from the Covid-19 pandemic.

The two-week closures, focused around its headquarters in Derby, will affect all of the 19,000 staff within Rolls-Royce's civil aerospace division, including 12,500 UK staff, who make airliner jet engines.

On Monday, boohoo joined online peer ASOS in snapping up retail brands from the failed Arcadia Group.

boohoo will buy the e-commerce and digital assets and associated intellectual property rights of Burton, Dorothy Perkins and Wallis for GBP25.2 million from Arcadia's joint-administrators.

"This is a great acquisition for the group as we extend our market share across a broader demographic, capitalising on growth opportunities as more and more customers shop online. We continue to grow our portfolio of brands and customer base, strengthening our position as a leader in global fashion e-commerce," boohoo Executive Chair Mahmud Kamani said.

The deal does not include any stores, however.

Philip Green's Arcadia Group went under back in November, putting 13,000 jobs at risk.

The UK high street continues to suffer from restrictions to control Covid-19. Like Arcadia Group, department store chain Debenhams also sunk into administration.

boohoo in January announced a deal for all of the intellectual property assets of Debenhams Retail for GBP55 million in cash.

Credit checking firm Experian noted that "data which is being illegally offered for sale on the internet, some of which may have been sourced from Serasa's non-sensitive marketing data". Serasa is a Brazilian unit owned by Experian. Like its parent, Serasa provides credit granting and validation services.

Experian said it is "continuing to carry out a detailed forensic investigation".

So far, the company explained, it knows that data offered includes photographs, social media logins, vehicles registrations, and "social security INSS", the latter concerning social security contributions in Brazil.

Experian however, noted that this data is not collected by Serasa.

"There is no evidence that positive or negative credit data has been illegally obtained from Serasa," the company said. "In spite of exhaustive investigations to date there is no evidence that our technology systems have been compromised."

In the FTSE 250, Electrocomponents posted improved revenue over the past four months, but noted "heightened freight, labour and logistical costs".

Revenue in the four months ended January 31 was up 8% annually on a life-for-like basis. In the second quarter to September, like-for-like revenue had fallen 4%. In the first-quarter ended June, it plunged 11%.

The distributor of industrial and electronic products left its annual profit outlook unchanged, "with stronger revenue growth offset by additional ongoing costs".

"The heightened freight, labour and logistical costs we are experiencing are likely to persist at a time of ongoing investment in our proposition. Despite these pressures, our confidence in our strategy remains strong," Electrocomponents said.

Power station operator Drax Group said it plans to bolster its Canadian unit with the purchase of Pinnacle Renewable Energy.

It will acquire Pinnacle at CAD11.30 per share, valuing the renewables firm's fully diluted equity at CAD385 million, about GBP226 million. The sum implies an enterprise value of CAD741 million.

Drax added: "The acquisition, which remains subject to Drax and Pinnacle shareholder approval, court approval, regulatory approvals and the satisfaction of certain other customary conditions, has been unanimously recommended by the board of Pinnacle and has the full support of Pinnacle's major shareholder, affiliates of ONCAP."

ONCAP holds about 31% of Pinnacle's shares, Drax noted.

Elsewhere in London, a regulatory filing showed Mike Ashley's Frasers Group sold its entire 24.93% stake in French Connection Group in a transaction on Thursday.

French Connection on Friday noted it received two separate takeover approaches. The proposals were from Spotlight Brands in conjunction with Gordon Brothers International and from Go Global Retail in conjunction with HMJ International Services.

Sterling was trading at USD1.3730 on Monday morning, largely flat from USD1.3728 at the London equities close on Friday.

The euro stood at USD1.2036 on Monday morning London time, up from USD1.2025 at the European equities close on Friday. Against the yen, the dollar was trading at JPY105.51, improved from JPY105.45 at the London market close on Friday.

The Japanese Nikkei 225 index jumped 2.2% on Monday, closing above the 29,000-point mark. In China, the Shanghai Composite closed 1.0% higher, while the Hang Seng index in Hong Kong is up 0.1%.

Brent oil was quoted at USD59.93 a barrel, up from USD59.62 a barrel at the London equities close Friday. Gold fetched USD1,816.77 an ounce, up from USD1,808.40.

By Eric Cunha; ericcunha@alliancenews.com;

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.